封面
市場調查報告書
商品編碼
1455402

2024 年生物工程技術世界市場報告

Bioengineering Technology Global Market Report 2024

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年生物工程技術市場規模將快速成長。預計到 2028 年將以 13.0% 的複合年成長率 (CAGR) 成長至 5,219.8 億美元。預測期內的預期成長可歸因於對細胞療法的日益關注、合成生物學的快速成長、精準醫學的進步、農業應用的擴大以及環境解決方案的使用的擴大。預測期內預計的主要趨勢包括先進的基因編輯技術、技術融合、精準醫學的進一步進步、全球合作與夥伴關係、合成生物學應用等。

慢性病盛行率的上升預計將推動未來生物工程技術市場的擴張。慢性病的特徵是長期、持續,並導致長期的健康狀況。生物工程技術在慢性病的管理和治療中發揮著重要作用,因為它們有潛力提供創新的解決方案、增強治療效果並改善患者的生活品質。例如,國家生物技術資訊中心2023年1月報告稱,慢性病患者預計將從2020年的7,152.2萬人增加到2050年的1.4266億人,成長99.5%。因此,慢性病盛行率的增加正在推動生物工程技術市場的成長。

生物工程技術市場的主要企業正專注於開發Mito Plus等創新技術產品,以推動再生醫學領域的發展。 Mito Plus 是一款最先進的 3D 生物列印機,旨在使用 3D 列印技術來生產類似於自然身體部位(包括活細胞)的組織和器官。例如,印度 3D 列印機製造和服務供應商Avay Biosciences Pvt. Mito Plus 於 2022 年 11 月推出了 Mito Plus。這款最先進的生物印表機被譽為同價格分佈中最先進的生物印表機之一,能夠列印多種應用。它使用生物材料並具有內建的紫外線固化選項。它還具有內建 HEPA 過濾器和溫度控制功能,除了加熱功能外,還可讓您將列印頭和列印床冷卻高達 4°C。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長,2023-2028、2033

第6章市場區隔

  • 全球生物工程技術市場,依產品、績效及預測細分,2018-2023、2023-2028、2033
  • 生物醫學工程
  • 基因工程
  • 生物技術
  • 人體組織工程
  • 生物力學工程
  • 生物材料
  • 生物力學工程
  • 奈米生物技術
  • 生物資訊學
  • 其他產品
  • 全球生物工程技術市場,依技術、績效及預測細分,2018-2023、2023-2028、2033
  • 奈米生物技術
  • 組織工程和再生
  • DNA序列測定
  • 基於細胞的檢測
  • 發酵
  • 全球生物工程技術市場,按應用細分、實際和預測,2018-2023、2023-2028、2033
  • 健康
  • 糧食和農業
  • 自然資源與環境

第 7 章 區域與國家分析

  • 全球生物工程技術市場,按地區、績效和預測,2018-2023、2023-2028、2033
  • 全球生物工程技術市場,按國家、績效和預測,2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 生物工程技術市場競爭格局
  • 生物工程技術市場公司概況
    • Pfizer Inc.
    • Johnson &Johnson
    • Roche Holding AG
    • Novartis AG
    • Bristol-Myers Squibb Company

第31章 其他重大及創新企業

  • Thermo Fisher Scientific
  • Abbott Laboratories
  • AstraZeneca plc
  • Medtronic plc
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Novo Nordisk A/S
  • Moderna Inc.
  • Becton Dickinson(BD)
  • Regeneron Pharmaceuticals, Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Inc.
  • Agilent Technologies
  • Lonza Group Ltd.
  • Intuitive Surgical

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r16403

Bioengineering technology involves applying principles and techniques from engineering and the natural sciences to develop technologies and solutions for understanding, manipulating, and utilizing biological systems, particularly in the fields of medicine, biology, and healthcare.

The primary types of products in bioengineering technology include biomedical engineering, genetic engineering, biotechnology, tissue engineering, biomechanics engineering, biomaterials, nano-biotechnology, bioinformatics, and others. Biomedical engineering entails applying engineering principles and design concepts to medicine and biology for healthcare purposes. It encompasses various technologies such as nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, and fermentation, and finds applications in health, food and agriculture, natural resources, and the environment.

The bioengineering technology market research report is one of a series of new reports from The Business Research Company that provides bioengineering technology market statistics, including bioengineering technology industry global market size, regional shares, competitors with a bioengineering technology market share, detailed bioengineering technology market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineering technology industry. This bioengineering technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioengineering technology market size has grown rapidly in recent years. It will grow from $282.19 billion in 2023 to $320.38 billion in 2024 at a compound annual growth rate (CAGR) of 13.5%. The growth observed during the historic period can be attributed to several factors, including the increasing aging population, rising prevalence of chronic diseases, growth in the bioengineering technology market, favorable government initiatives, and the adoption of genetic engineering strategies.

The bioengineering technology market size is expected to see rapid growth in the next few years. It will grow to $521.98 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The projected growth in the forecast period can be attributed to an increased focus on cell therapies, the rapid growth of synthetic biology, advancements in precision medicine, a growing application in agriculture, and an expanded use in environmental solutions. Major trends anticipated in the forecast period include advanced gene editing techniques, the convergence of technologies, further advancements in precision medicine, global collaboration and partnership, and the applications of synthetic biology.

The rising prevalence of chronic diseases is poised to drive the expansion of the bioengineering technology market in the future. Chronic diseases are characterized by their prolonged and persistent nature, leading to long-term health conditions. Bioengineering technology plays a crucial role in managing and treating chronic diseases due to its potential to offer innovative solutions, enhance outcomes, and improve the quality of life for patients. For instance, the National Centre for Biotechnology Information reported in January 2023 that chronic conditions are expected to increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. Consequently, the growing prevalence of chronic diseases is fueling the growth of the bioengineering technology market.

Key players in the bioengineering technology market are focusing on developing innovative technological products, such as Mito Plus, to advance the field of regenerative medicine. Mito Plus is a cutting-edge 3D bioprinter designed to produce tissues or organs resembling natural body parts, containing living cells, using 3D printing technology. For example, Avay Biosciences Pvt. Ltd., an India-based manufacturer and service provider of 3D printers, introduced Mito Plus in November 2022. This state-of-the-art bioprinter is hailed as one of the most advanced in its price range, capable of printing a wide range of biomaterials and featuring built-in UV curing options. It also incorporates HEPA filters and temperature control, enabling cooling of the printhead and print bed by up to 4 degrees Celsius, as well as heating capabilities.

In March 2023, Ginkgo Bioworks, a US-based horizontal platform for cell programming, acquired FGen AG for an undisclosed sum. This acquisition strengthens Ginkgo's position as a leader in the bioengineering field, providing it with a robust tool for strain development and optimization across various industries. FGen AG is a Switzerland-based bioengineering company.

Major companies operating in the bioengineering technology market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Moderna Inc., Becton Dickinson (BD), Regeneron Pharmaceuticals, Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Agilent Technologies, Lonza Group Ltd., Intuitive Surgical, Illumina, Inc, Bio-Rad Laboratories, Ginkgo Bioworks, Verve Therapeutics, Inc., CRISPR Therapeutics

North America was the largest region in the bioengineering technology market in 2023. The regions covered in the bioengineering technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioengineering technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bioengineering technology market includes revenues earned by entities service such as medical diagnostic services, pharmaceutical services, personalized medicine services, engineering, and nanotechnology in medicine services, biological data analysis services, regenerative medicine services, and health information technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The bioengineering technology market consists of sales of implantable medical devices, wearable health monitoring devices, biomedical imaging equipment, and diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioengineering Technology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioengineering technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioengineering technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioengineering technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Biomedical Engineering; Genetic Engineering; Biotechnology; Tissue Engineering; Biomechanics Engineering; Biomaterial; Biomechanical Engineering; Nano-biotechnology; Bioinformatics; Other Products
  • 2) By Technology: Nanobiotechnology; Tissue Engineering and Regeneration; DNA Sequencing; Cell-based Assays; Fermentation
  • 3) By Application: Health; Food And Agriculture; Natural Resources And Environment
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Novartis AG; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioengineering Technology Market Characteristics

3. Bioengineering Technology Market Trends And Strategies

4. Bioengineering Technology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bioengineering Technology Market Size and Growth

  • 5.1. Global Bioengineering Technology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bioengineering Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bioengineering Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioengineering Technology Market Segmentation

  • 6.1. Global Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biomedical Engineering
  • Genetic Engineering
  • Biotechnology
  • Tissue Engineering
  • Biomechanics Engineering
  • Biomaterial
  • Biomechanical Engineering
  • Nano-biotechnology
  • Bioinformatics
  • Other Products
  • 6.2. Global Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nanobiotechnology
  • Tissue Engineering and Regeneration
  • DNA Sequencing
  • Cell-based Assays
  • Fermentation
  • 6.3. Global Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Health
  • Food And Agriculture
  • Natural Resources And Environment

7. Bioengineering Technology Market Regional And Country Analysis

  • 7.1. Global Bioengineering Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bioengineering Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioengineering Technology Market

  • 8.1. Asia-Pacific Bioengineering Technology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioengineering Technology Market

  • 9.1. China Bioengineering Technology Market Overview
  • 9.2. China Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioengineering Technology Market

  • 10.1. India Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioengineering Technology Market

  • 11.1. Japan Bioengineering Technology Market Overview
  • 11.2. Japan Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioengineering Technology Market

  • 12.1. Australia Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioengineering Technology Market

  • 13.1. Indonesia Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioengineering Technology Market

  • 14.1. South Korea Bioengineering Technology Market Overview
  • 14.2. South Korea Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioengineering Technology Market

  • 15.1. Western Europe Bioengineering Technology Market Overview
  • 15.2. Western Europe Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioengineering Technology Market

  • 16.1. UK Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioengineering Technology Market

  • 17.1. Germany Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioengineering Technology Market

  • 18.1. France Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioengineering Technology Market

  • 19.1. Italy Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioengineering Technology Market

  • 20.1. Spain Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioengineering Technology Market

  • 21.1. Eastern Europe Bioengineering Technology Market Overview
  • 21.2. Eastern Europe Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioengineering Technology Market

  • 22.1. Russia Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioengineering Technology Market

  • 23.1. North America Bioengineering Technology Market Overview
  • 23.2. North America Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioengineering Technology Market

  • 24.1. USA Bioengineering Technology Market Overview
  • 24.2. USA Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioengineering Technology Market

  • 25.1. Canada Bioengineering Technology Market Overview
  • 25.2. Canada Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioengineering Technology Market

  • 26.1. South America Bioengineering Technology Market Overview
  • 26.2. South America Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioengineering Technology Market

  • 27.1. Brazil Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioengineering Technology Market

  • 28.1. Middle East Bioengineering Technology Market Overview
  • 28.2. Middle East Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioengineering Technology Market

  • 29.1. Africa Bioengineering Technology Market Overview
  • 29.2. Africa Bioengineering Technology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bioengineering Technology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bioengineering Technology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioengineering Technology Market Competitive Landscape And Company Profiles

  • 30.1. Bioengineering Technology Market Competitive Landscape
  • 30.2. Bioengineering Technology Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holding AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bioengineering Technology Market Other Major And Innovative Companies

  • 31.1. Thermo Fisher Scientific
  • 31.2. Abbott Laboratories
  • 31.3. AstraZeneca plc
  • 31.4. Medtronic plc
  • 31.5. Gilead Sciences Inc.
  • 31.6. Amgen Inc.
  • 31.7. Novo Nordisk A/S
  • 31.8. Moderna Inc.
  • 31.9. Becton Dickinson (BD)
  • 31.10. Regeneron Pharmaceuticals, Inc.
  • 31.11. Biogen Inc.
  • 31.12. Vertex Pharmaceuticals Inc.
  • 31.13. Agilent Technologies
  • 31.14. Lonza Group Ltd.
  • 31.15. Intuitive Surgical

32. Global Bioengineering Technology Market Competitive Benchmarking

33. Global Bioengineering Technology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioengineering Technology Market

35. Bioengineering Technology Market Future Outlook and Potential Analysis

  • 35.1 Bioengineering Technology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bioengineering Technology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bioengineering Technology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer